Key result
Non-thoracotomy ICD lead systems were associated with prolonged intraoperative testing time compared to thoracotomy systems.
Why the study?
Does the non-thoracotomy ICD lead system affect operative morbidity and mortality compared to the thoracotomy system?
Observational (n=34)
No
Does the non-thoracotomy ICD lead system affect operative morbidity and mortality compared to the thoracotomy system?
Early institutional experience with non-thoracotomy ICD leads demonstrated high implant success (88.2%) but highlighted increased intraoperative morbidity and prolonged testing times compared to traditional thoracotomy approaches.
Answers are grounded in this paper and cite their sources.
Early non-thoracotomy ICD experience suggests feasible expansion to higher-risk patients; leaves open need for prospective outcome data.
Introduction of non-thoracotomy lead systems (Medtronic, Inc.) for the implantable cardioverter defibrillator (ICD) has expanded the indications for use of this mode of therapy. Patients previously considered "too ill" to undergo a thoracotomy as well as patients who are at a high risk for developing sudden death but without previous cardiac arrest, are now considered candidates. The initial experience with the non-thoracotomy lead system at our institution was analyzed for morbidity and mortality. Thirty-four patients underwent attempted intravascular lead implantation, with 30 having initial successful implantation (88.2%). There were 23 males; average ejection fraction (EF) was 38.6%. Three patients developed pulmonary edema and low output immediately after the procedure. Three patients developed electromechanical dissociation during defibrillation threshold testing. A prolonged testing time for the non-thoracotomy lead system was noted when compared to the thoracotomy system (57.39 vs 32.30 min; P < 0.0000). There were more intraoperative morbidities with the non-thoracotomy leads than with the thoracotomy system. There were no perioperative deaths. The potential consequences of prolonged anesthesia time and extensive defibrillation threshold testing should be considered when choosing the route of ICD implant, the type of anesthesia, and the intraoperative testing protocol for each patient.
No takes yet. Share an insight, caveat, or question.
Frame et al. (1993) conducted an observational in High risk for sudden death requiring ICD (n=34). Non-thoracotomy ICD lead system vs. Thoracotomy ICD lead system was evaluated on Intraoperative testing time (minutes) (p=< 0.0000). Non-thoracotomy ICD lead systems were associated with prolonged intraoperative testing time compared to thoracotomy systems.
Synapse has enriched 10 related papers. Consider them for comparative context: